These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 173519

  • 1. Atypical myasthenia gravis. A neurophysiological and pharmacological study.
    Bergmans J, Cleppe D, Diniz P, Rosselle N.
    Electromyogr Clin Neurophysiol; 1975 Jul; 15(3):271-7. PubMed ID: 173519
    [No Abstract] [Full Text] [Related]

  • 2. [Single fiber electromyography in myasthenia gravis].
    Huang SR.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Dec; 19(6):345-8. PubMed ID: 3034526
    [No Abstract] [Full Text] [Related]

  • 3. [Electromyographic characteristics of lysthenon action on neuromuscular transmission in myasthenia patients].
    Kolomenskaia EA, Sigaev VV, Perel'man LB.
    Eksp Khir Anesteziol; 1972 Dec; 17(4):71-5. PubMed ID: 4345049
    [No Abstract] [Full Text] [Related]

  • 4. Acute effects of verapamil on neuromuscular transmission in patients with myasthenia gravis.
    Lee SC, Ho ST.
    Proc Natl Sci Counc Repub China B; 1987 Jul; 11(3):307-12. PubMed ID: 2827211
    [Abstract] [Full Text] [Related]

  • 5. The pharmacological basis for the treatment of myasthenia gravis.
    Flacke W.
    Pharmacol Physicians; 1970 Jun; 4(6):1-7. PubMed ID: 4316342
    [No Abstract] [Full Text] [Related]

  • 6. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
    Stickler DE, Stickler LL.
    Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882
    [Abstract] [Full Text] [Related]

  • 7. Benefit from alternate-day prednisone in myasthenia gravis.
    Warmolts JR, Engel WK.
    N Engl J Med; 1972 Jan 06; 286(1):17-20. PubMed ID: 4331158
    [No Abstract] [Full Text] [Related]

  • 8. [Neurophysiological monitoring of the myasthenia patient during and after thymectomy (author's transl)].
    Bergmans J.
    Ann Chir; 1980 Mar 06; 34(3):182-7. PubMed ID: 6245617
    [No Abstract] [Full Text] [Related]

  • 9. [Mechanism of action of muscle relaxants and its clinical problems].
    Suzuki H.
    Masui; 1974 Aug 06; 23(8):679-92. PubMed ID: 4372420
    [No Abstract] [Full Text] [Related]

  • 10. The effect of cholinesterase inhibitors of SFEMG in myasthenia gravis.
    Massey JM, Sanders DB, Howard JF.
    Muscle Nerve; 1989 Feb 06; 12(2):154-5. PubMed ID: 2540433
    [Abstract] [Full Text] [Related]

  • 11. Adverse drug effects on neuromuscular transmission.
    Howard JF.
    Semin Neurol; 1990 Mar 06; 10(1):89-102. PubMed ID: 2161128
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Neuromuscular transmission in patients with myasthenia gravis treated by plasmapheresis and hemosorption].
    Marshaniia ZS, Sanadze AG, Kil'diushevskiĭ AV, Startsev AI.
    Klin Med (Mosk); 1987 Jul 06; 65(7):107-10. PubMed ID: 2822998
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neurophysiological aspects of diagnosis in neuromuscular transmission defects--an update.
    Stålberg E.
    Electroencephalogr Clin Neurophysiol Suppl; 1999 Jul 06; 50():377-85. PubMed ID: 10689484
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Physiology of neuromuscular transmission.
    Roberts DV, Wilson A.
    Physiotherapy; 1972 Aug 06; 58(8):277-9. PubMed ID: 4360596
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.